MetaCap

Replimune Group Financial Statements

NASDAQ: REPLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

19.07-0.16 (-0.83%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Replimune Group revenue and earnings

Replimune Group reported a net loss of $313.9 million, compared with a loss of $247.3 million a year earlier. Diluted earnings per share came in at -$3.38.

Summary generated from market data by MetaCap's automated system. Methodology

Replimune Group income statement (annual)

Replimune Group annual income statement
Fiscal year (USD)FY 20262026-03-31FY 20252025-03-31FY 20242024-03-31FY 20232023-03-31FY 20222022-03-31FY 20212021-03-31FY 20192020-03-31FY 20192019-03-31FY 20182018-03-31FY 20172017-03-31
Operating Expenses319.92M261.63M234.77M177.08M118.31M79.95M56.20M30.95M19.23M9.65M
Research & Development221.18M189.45M174.96M126.53M79.55M56.75M38.76M22.17M13.52M6.94M
Selling, General & Admin98.73M72.18M————————
Operating Income-319.92M-261.63M-234.77M-177.08M-118.31M-79.95M-56.20M-30.95M-19.23M-9.65M
Interest Expense6.80M5.78M4.50M1.96M0818.00K734.00K———
Other Income (Expense)5.43M14.80M19.39M3.08M278.00K-915.00K3.57M112.00K-473.00K1.94M
Pretax Income-314.49M-246.83M-215.39M-174.00M-118.04M-80.87M-52.63M-30.83M-19.70M-7.70M
Income Tax-551.00K468.00K408.00K288.00K000000
Net Income-313.94M-247.30M-215.79M-174.28M-118.04M-80.87M-52.63M-30.83M-19.70M-7.70M
Net Income growth (YoY)——————————
EPS (Basic)-3.38-3.07-3.24-2.99-2.26-1.75-1.54-1.33-3.96-1.55
EPS (Diluted)-3.38-3.07-3.24-2.99-2.26-1.75-1.54-1.33-3.96-1.55
Shares Outstanding (Basic)92.80M80.56M66.57M58.21M52.21M46.25M34.26M23.20M4.98M4.97M
Shares Outstanding (Diluted)92.80M80.56M66.57M58.21M52.21M46.25M34.26M23.20M4.98M4.97M
EBITDA-316.59M-258.13M-232.12M-174.63M-116.17M-78.24M-55.66M-30.80M-19.12M-9.53M

This table shows 10 annual periods of Replimune Group's income statement, from FY 2026 back to FY 2017, across 14 line items including operating expenses, research & development, selling, general & admin. Values in USD; B = billions, M = millions. Fiscal periods follow REPL's reporting calendar. What is a income statement?

More financial data